Display options
Cite
Bortolin M, Bidossi A, De Vecchi E, et al. . Front Microbiol. 2017;8:1039doi: 10.3389/fmicb.2017.01039.
Bortolin, M., Bidossi, A., De Vecchi, E., Avveniente, M., & Drago, L. (2017). . Frontiers in microbiology, 81039. https://doi.org/10.3389/fmicb.2017.01039
Bortolin, Monica, et al. "." Frontiers in microbiology vol. 8 (2017): 1039. doi: https://doi.org/10.3389/fmicb.2017.01039
Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L. . Front Microbiol. 2017 Jun 08;8:1039. doi: 10.3389/fmicb.2017.01039. eCollection 2017. PMID: 28642751; PMCID: PMC5462991.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2017 Jun 08;8:1039. doi: 10.3389/fmicb.2017.01039. eCollection 2017.

[No title available]

Frontiers in microbiology

Monica Bortolin, Alessandro Bidossi, Elena De Vecchi, Maura Avveniente, Lorenzo Drago

Affiliations

  1. Laboratory of Clinical Chemistry and Microbiology, IRCCS Galeazzi Orthopaedic InstituteMilan, Italy.
  2. Laboratory of Clinical Microbiology, Department of Biomedical Sciences for Health, University of MilanMilan, Italy.

PMID: 28642751 PMCID: PMC5462991 DOI: 10.3389/fmicb.2017.01039

Abstract

Skin and soft tissue infections

Keywords: chlorquinaldol; fusidic acid; gentamicin; minimum bactericidal concentration; minimum inhibitory concentration; skin infections; time-kill curves

References

  1. Yakugaku Zasshi. 2011;131(11):1653-9 - PubMed
  2. Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S69-78 - PubMed
  3. PLoS One. 2016 Dec 9;11(12 ):e0167638 - PubMed
  4. G Ital Dermatol Venereol. 2014 Aug;149(4):453-9 - PubMed
  5. Vet Med Nauki. 1987;24(7):81-7 - PubMed
  6. Mykosen. 1980 Jun;23(6):320-4 - PubMed
  7. An Bras Dermatol. 2012 Nov-Dec;87(6):857-61 - PubMed
  8. Drug Des Devel Ther. 2013 Oct 04;7:1157-78 - PubMed
  9. Dermatologica. 1979;158(1):72-9 - PubMed
  10. Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S35-44 - PubMed
  11. J Pediatr. 1980 Dec;97(6):972-8 - PubMed
  12. Nat Prod Commun. 2011 May;6(5):597-602 - PubMed
  13. Infect Control Hosp Epidemiol. 2007 Nov;28(11):1290-8 - PubMed
  14. Wiad Lek. 1992 Apr;45(7-8):263-9 - PubMed
  15. BMC Infect Dis. 2013 May 30;13:252 - PubMed
  16. J Invest Dermatol. 1956 Feb;26(2):143-7 - PubMed
  17. Clin Infect Dis. 2006 Feb 1;42(3):394-400 - PubMed
  18. J Int Med Res. 1983;11 Suppl 1:48-52 - PubMed
  19. Antimicrob Agents Chemother. 2007 Mar;51(3):1105-6 - PubMed
  20. Biochem J. 1975 Jun;147(3):401-10 - PubMed
  21. Pathol Biol (Paris). 1991 Feb;39(2):136-9 - PubMed
  22. Expert Opin Ther Pat. 2015;25(8):931-7 - PubMed
  23. Antibiot Chemother (Northfield). 1960 Dec;10:771-2 - PubMed
  24. Biochim Biophys Acta. 1977 Jul 15;477(2):102-11 - PubMed
  25. Diagn Microbiol Infect Dis. 2007 Jan;57(1):7-13 - PubMed
  26. Akush Ginekol (Sofiia). 1996;35(4):49-50 - PubMed
  27. Dermatologica. 1979;159(3):239-44 - PubMed
  28. Int J Dermatol. 2013 Jul;52(7):876-81 - PubMed
  29. Int J Antimicrob Agents. 2016 Jul;48(1):19-26 - PubMed
  30. Drug Target Insights. 2016 May 29;10(Suppl 1):9-13 - PubMed
  31. J Antimicrob Chemother. 1977 May;3(3):213-7 - PubMed
  32. APMIS Suppl. 2013 May;(136):1-51 - PubMed
  33. J Antimicrob Chemother. 2010 Jul;65(7):1424-7 - PubMed
  34. Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S45-58 - PubMed
  35. Clin Infect Dis. 2014 Nov 15;59(10):1451-4 - PubMed
  36. Drugs. 1988;36 Suppl 5:24-33 - PubMed
  37. Trans N Y Acad Sci. 1955 Dec;18(2):161-74 - PubMed
  38. J Clin Pathol. 1977 Feb;30(2):165-7 - PubMed

Publication Types